Multifactor Strategies for TB Prevention and Control

1. Nutritional Status and TB Risk Evidence from a large Chinese cohort shows that higher BMI is independently protective against TB, with each one-unit increase lowering incidence by nearly 8%. Overweight and obese individuals had the lowest TB risk, while underweight participants experienced the highest, though statistical significance was limited after adjustment. This protective association held across age and sex groups, reinforcing the role of nutritional status in TB susceptibility. The findings align with prior research linking malnutrition to greater TB risk and suggest that improving BMI may have contributed to China’s recent TB declines.

See also: Yoseph Samodra

Policy implications are clear: screening should target individuals with low BMI, particularly in high-burden settings. Nutritional interventions at the community level could serve as effective TB prevention strategies alongside conventional case detection and treatment programs. By integrating dietary support into TB control frameworks, public health efforts could address both malnutrition and infection risk in a single, cost-effective approach.

---

2. Community-Based TB Detection and Treatment Uganda’s national TB campaigns in 2022 demonstrated the power of community-driven interventions. Within a year, coverage expanded from 76% to 100% of districts, diagnostic unit participation doubled, and reach scaled from 2.9% to 11.6% of the population. Case notification rates jumped by 24% in the first campaign and 59% in the second, aided by mobile diagnostics, preventive therapy for 23,000 high-risk contacts, and integration of leprosy screening. Strong governmental and partner support enabled rapid expansion and ensured operational sustainability.

These results highlight that community mobilization, when coupled with logistical innovations, can dramatically improve TB detection and treatment initiation. Sustaining funding, refining operational tools, and maintaining political commitment are essential to ensuring these gains translate into lasting reductions in TB burden, especially in remote and underserved areas.

---

3. TB–Diabetes Interaction and Immune Dysfunction TB patients with diabetes mellitus (TB-DM) display a distinct biological profile—marked by elevated inflammatory proteins, atherogenic lipid patterns, and sustained immune activation even after two months of therapy. These abnormalities correlate with worse outcomes, including persistent sputum positivity, suggesting prolonged infection and elevated cardiovascular risk. Hyperglycemia exacerbates immune dysfunction by impairing macrophage oxidative and cytokine responses, downregulating critical receptors, and dampening pathogen clearance.

Managing TB-DM requires a tailored approach. Beyond standard TB therapy, clinicians should consider blood glucose control, anti-inflammatory agents, and lipid-lowering treatments such as statins. Biomarkers could help predict treatment response, enabling early intervention for high-risk patients. Viewing TB-DM as a distinct phenotype, rather than a coincidental comorbidity, may improve both infection control and long-term health outcomes.

---

4. Environmental and Microbiome Factors in TB Control Research in high-density urban settings confirms that overcrowded housing and close contact with TB patients are significant risk factors for infection, independent of individual knowledge or demographics. Structural interventions—improving ventilation, reducing crowding, and enhancing contact tracing—are therefore essential for disrupting transmission in these environments.

The gut microbiome also plays a critical role in TB immunity, influencing T cell activity and treatment outcomes. Long-term use of anti-TB antibiotics can disrupt this microbial balance, potentially weakening host defenses and compounding risks in patients with structural lung damage from previous infections. Integrating microbiome preservation strategies, along with post-treatment lung health monitoring, could prevent reinfection, reduce opportunistic pathogens, and improve quality of life for TB survivors.

References:

1. Chen, J., Zha, S., Hou, J., Lu, K., Qiu, Y., Yang, R., Li, L., Yang, Y. and Xu, L., 2022. Dose–response relationship between body mass index and tuberculosis in China: a population-based cohort study. BMJ open, 12(3), p.e050928.
2. Turyahabwe, S., Bamuloba, M., Mugenyi, L., Amanya, G., Byaruhanga, R., Imoko, J.F., Nakawooya, M., Walusimbi, S., Nidoi, J., Burua, A. and Sekadde, M., 2024. Community tuberculosis screening, testing and care, Uganda. Bulletin of the World Health Organization, 102(6), p.400.
3. Brake, J., Ajie, M., Sumpter, N.A., Koesoemadinata, R.C., Soetedjo, N.N., Santoso, P., Alisjahbana, B., Ruslami, R., Hill, P. and van Crevel, R., 2025. Inflammation and dyslipidaemia in combined diabetes and tuberculosis; a cohort study. iScience, 28(6).
4. Sopiani, P., Maemun, S., Azijah, I., Pratiwi, T.Z. and Saputra, R., 2025. Analysis of Risk Factors for Pulmonary Tuberculosis in Cirascas District, East Jakarta, 2022. The Indonesian Journal of Infectious Diseases, 11(1), pp.42-51.
5. Chaubey, G.K., Modanwal, R., Dilawari, R., Talukdar, S., Dhiman, A., Chaudhary, S., Patidar, A., Raje, C.I. and Raje, M., 2024. Chronic hyperglycemia impairs anti-microbial function of macrophages in response to Mycobacterium tuberculosis infection. Immunologic Research, 72(4), pp.644-653.
6. Wu, Y., Wang, C. and Li, Y., 2025. Status and outlook of pulmonary tuberculosis coinfection. Journal of Research in Medical Sciences, 30(1), p.34.

TBC 070

Tuberculosis in Jakarta

A case-control study aimed to explore the role of housing conditions and interpersonal contact in the spread of pulmonary tuberculosis (TB) among adult patients at the Ciracas Primary Health Center. The researchers focused on key environmental risk factors, notably residential density and direct contact with TB patients, given their suspected influence on TB transmission in high-density urban settings.

The methodology was well-structured for the research question. By employing a case-control design, the study efficiently compared patients diagnosed with TB (cases) and those without TB (controls). The matching technique—both frequency and individual—helped control for major confounders such as age, sex, and contact history. Data collection combined clinical records and validated questionnaires to ensure both reliability and validity of findings.

Results confirmed that high housing density and previous contact with TB patients were strongly associated with TB infection. Interestingly, despite high levels of TB-related knowledge among TB patients, this did not correlate with a lower risk of infection. Similarly, sociodemographic traits, although descriptively different between groups, were not statistically associated with TB risk.

These findings underscore the importance of environmental and behavioral interventions in TB control. The fact that good knowledge alone does not prevent disease suggests that structural conditions—like crowded living spaces—play a more decisive role. When TB patients share small, poorly ventilated homes with others, the likelihood of airborne transmission rises significantly.

To reduce TB transmission, public health strategies must move beyond individual-level education and include structural reforms. These may include improving housing conditions, enhancing ventilation, and tracing and managing close contacts of TB patients more proactively. Addressing these key factors could help break the cycle of infection in high-density communities.

References:

1. Sopiani, P., Maemun, S., Azijah, I., Pratiwi, T.Z. and Saputra, R., 2025. Analysis of Risk Factors for Pulmonary Tuberculosis in Cirascas District, East Jakarta, 2022. The Indonesian Journal of Infectious Diseases, 11(1), pp.42-51.

Tuberculosis-diabetes comorbidities

A study offers crucial insight into how diabetes mellitus alters the immune and metabolic response in individuals with tuberculosis (TB). By comparing inflammatory and lipid profiles across individuals with TB, DM, and both (TB-DM), the researchers found that TB-DM presents a unique biological signature. This includes elevated inflammatory proteins not seen in TB or DM alone, and a pro-atherogenic lipid profile marked by high VLDL and ApoB.

Notably, the study demonstrates that while inflammation generally decreases after two months of TB treatment, certain inflammatory markers remain disproportionately high in TB-DM, suggesting sustained immune activation. These inflammatory profiles were also linked to worse TB outcomes, particularly continued sputum positivity, which suggests persistent infection and increased treatment failure risk.

Lipid metabolism was equally impacted. TB-DM patients exhibited lipid patterns more closely resembling diabetic individuals, but with distinct increases in risk-associated markers like ApoB. Even during treatment, lipid levels, especially LDLs and ApoB, rose more significantly in TB-DM, reinforcing cardiovascular risk concerns.

These findings underscore the need to view TB-DM as a distinct clinical phenotype, not merely a coexistence of two conditions. Therapeutic strategies may need to be adapted for this group, including consideration of statins or anti-inflammatory agents. The data also support the potential use of inflammatory and lipid biomarkers to predict treatment response and tailor interventions.

Importantly, the study provides one of the largest datasets to date in this domain, strengthening the reliability of the conclusions and providing a framework for future personalized approaches in TB-DM care.

Sources:

1. Brake, J., Ajie, M., Sumpter, N.A., Koesoemadinata, R.C., Soetedjo, N.N., Santoso, P., Alisjahbana, B., Ruslami, R., Hill, P. and van Crevel, R., 2025. Inflammation and dyslipidaemia in combined diabetes and tuberculosis; a cohort study. iScience, 28(6).

Economic Burden and Transmission Dynamics

Economic Burden and Cost-Effectiveness of TB Treatments

• The BPaL regimen for drug-resistant TB in the Philippines significantly reduces both direct and indirect patient costs compared to existing regimens.
• Economic evaluations (ACER and ICER) showed BPaL is cost-effective under GDP-based thresholds.
• BPaL also improves treatment success rates, highlighting economic and health benefits.
• Lower catastrophic health expenditures and reduced healthcare visits make BPaL advantageous for real-world implementation.
• The study recommends national TB programs transition toward routine BPaL adoption.

---

Diabetes Costs and Integration with TB Care

• DM outpatient visits in the Philippines accounted for 3–13% of all visits; monthly drug costs per patient averaged USD 7.67.
• Costs varied by diagnostic test: RPG USD 1.67, FBS USD 2.99, OGTT USD 23.72.
• Staff time was the largest cost driver for non-lab services, while consumables dominated lab costs.
• The cost per DM case detected among TB patients was lowest using RPG plus FBS algorithms (USD 17.43).
• Findings highlight the need for planning integrated TB-DM services and understanding economic burdens.

---

Transmission Dynamics and Risk Factors for TB

• In Lima, Peru, genomic sequencing of 2,500 TB cases identified over 1,400 direct transmission pairs.
• Higher transmission was linked to younger age, male gender, smoking, drinking, and incarceration.
• Cavitary disease and previous TB increased transmissibility.
• The study demonstrates the power of genomic tools in identifying high-risk groups for targeted interventions.
• Former prisoners and substance users should be prioritized in TB control efforts.

---

Impact of Smoking Cessation on Household TB Transmission

• Recent smoking cessation among TB patients significantly reduced TB infection risk in child contacts.
• Children of recent quitters had infection rates similar to those of never-smokers.
• Risk ratios for infection were about half compared to contacts of active smokers.
• Results were consistent after adjusting for disease severity and restricting to younger children.
• The study underscores smoking cessation as an effective, rapid intervention to lower TB spread in households.

---

TB and Diabetes Syndemic: Challenges and Opportunities

• Diabetes delays TB diagnosis, worsens disease severity (e.g., cavitary lesions), and increases mortality and relapse rates.
• Hyperglycemia—whether pre-existing or treatment-induced—predicts worse TB outcomes.
• M. tuberculosis infection can disrupt metabolism, contributing to insulin resistance.
• Certain diabetes medications (e.g., metformin) may improve TB immunopathology, while TB treatments can worsen glycemic control.
• Integrated care models with enhanced screening, tailored regimens, and glycemic monitoring are critical to improving outcomes in this syndemic.

See also: Lin TB Lab

References:

1. Yamanaka, T., Castro, M.C., Ferrer, J.P., Solon, J.A., Cox, S.E., Laurence, Y.V. and Vassall, A., 2024. Health system costs of providing outpatient care for diabetes in people with TB in the Philippines. IJTLD open, 1(3), pp.124-129.
2. Evans, D., Hirasen, K., Casalme, D.J., Gler, M.T., Gupta, A. and Juneja, S., 2024. Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines. IJTLD open, 1(6), pp.242-249.
3. Chu, A.L., Lecca, L.W., Calderón, R.I., Contreras, C.C., Yataco, R.M., Zhang, Z., Becerra, M.C., Murray, M.B. and Huang, C.C., 2021. Smoking cessation in tuberculosis patients and the risk of tuberculosis infection in child household contacts. Clinical Infectious Diseases, 73(8), pp.1500-1506.
4. Trevisi, L., Brooks, M.B., Becerra, M.C., Calderón, R.I., Contreras, C.C., Galea, J.T., Jimenez, J., Lecca, L., Yataco, R.M., Tovar, X. and Zhang, Z., 2024. Who transmits tuberculosis to whom: a cross-sectional analysis of a cohort study in Lima, Peru. American Journal of Respiratory and Critical Care Medicine, 210(2), pp.222-233.
5. Magodoro, I., Kotze, L., Stek, C.J., West, A., Le Roux, A., Sobratee, N., Taliep, A., Hamada, Y., Dave, J.A., Rangaka, M.X. and Parihar, S.P., 2025. Clinical, metabolic and immune interaction between tuberculosis and diabetes mellitus: implications and opportunities for therapies. Expert Opinion on Pharmacotherapy.
6. Pratiwi, R.D., Alisjahbana, B., Subronto, Y.W., Priyanta, S. and Suharna, S., 2025. Implementation of an information system for tuberculosis in healthcare facilities in Indonesia: evaluation of its effectiveness and challenges. Archives of Public Health, 83(1), pp.1-18.

Yoseph Samodra

TBC 068

Dose–response relationship between BMI and tuberculosis

Tuberculosis remains a pressing public health problem in China, especially in regions with limited resources and high disease burden. Recognizing that factors such as age, sex, diabetes, and undernutrition may influence TB risk, this study set out to clarify the role of body mass index (BMI) in determining TB incidence in adults. The researchers conducted a large-scale, prospective cohort study in Dongchuan County, Yunnan Province, following over 26,000 participants for more than two years.

The methodology was robust, using repeated TB screenings and carefully measured BMI classifications. By categorizing individuals into underweight, normal weight, and overweight/obese groups, the investigators were able to track how different BMI levels related to new cases of active TB. They found that TB incidence rates were highest among those who were underweight and lowest among individuals classified as overweight or obese. Importantly, the study documented a clear dose–response relationship: for every one-unit increase in BMI, TB incidence decreased by almost 8%.

Multivariate analyses confirmed that overweight and obesity were significantly protective against TB even after adjusting for important confounders, including diabetes status and prior TB history. Subgroup analyses revealed that this protective effect was consistent in men, women, and the elderly, suggesting the findings are broadly applicable across different demographic profiles.

These results align well with prior evidence linking malnutrition to higher susceptibility to TB infection and progression. Notably, the study highlighted that BMI improvements could have contributed to recent TB declines in China, underscoring the role of nutritional status in TB control strategies. While underweight status was associated with higher TB rates, this association did not reach statistical significance in adjusted models, possibly due to limited power in the underweight subgroup.

Overall, this research provides valuable evidence that higher BMI can be an independent protective factor against TB. These findings support prioritizing targeted TB screening among individuals with low BMI and suggest that community-level nutritional interventions could help lower TB incidence further. For policymakers and clinicians, the study highlights an opportunity to integrate nutrition-focused strategies into TB prevention programs, especially in regions where undernutrition remains prevalent.

References:

1. Chen, J., Zha, S., Hou, J., Lu, K., Qiu, Y., Yang, R., Li, L., Yang, Y. and Xu, L., 2022. Dose–response relationship between body mass index and tuberculosis in China: a population-based cohort study. BMJ open, 12(3), p.e050928.

The re-emerging association between tuberculosis and diabetes

Diabetes mellitus and tuberculosis are two major global health challenges whose intersection has been observed for more than a century. Historical records show that even before the discovery of insulin, TB was a frequent complication among patients with poorly controlled diabetes. Early studies, while limited in design, suggested that TB prevalence among diabetic patients was considerably higher than in the general population. This trend persisted across different eras and geographies.

The introduction of insulin therapy improved the survival of diabetic patients, inadvertently increasing the number of individuals who lived long enough to develop TB. Meanwhile, global shifts in lifestyle and nutrition led to a dramatic rise in obesity and type 2 diabetes, especially in regions where TB remains endemic. In contemporary times, some communities report that up to half of TB patients also have diabetes, underscoring the importance of this dual burden.

Beyond prevalence, disease severity and chronicity of diabetes have consistently emerged as key determinants of TB risk. Patients with prolonged hyperglycemia or a history of diabetic coma appear especially susceptible, likely due to compromised immune surveillance against Mycobacterium tuberculosis. This observation is consistent across older autopsy studies and modern epidemiological analyses.

Importantly, the association between TB and diabetes may not be unidirectional. While diabetes increases TB risk, evidence also suggests that TB can worsen glucose tolerance, either transiently through stress hyperglycemia or possibly by inflicting damage on pancreatic tissue. However, rigorous studies clarifying this pathway remain limited.

Treatment outcomes for patients with both diseases have historically been poor. Delays in diagnosis, limited therapeutic options, and socioeconomic disadvantage all contributed to high mortality rates among TB-DM patients in the past. Even today, diabetes remains a predictor of delayed TB clearance, treatment failure, and relapse.

Overall, the historical literature, despite its methodological limitations, provides valuable insights that remain relevant. It underscores the need for integrated strategies addressing both diabetes management and TB control, especially in low-resource settings where the co-occurrence of both conditions is increasingly common.

References:

1. Cadena, J., Rathinavelu, S., Lopez-Alvarenga, J.C. and Restrepo, B.I., 2019. The re-emerging association between tuberculosis and diabetes: lessons from past centuries. Tuberculosis, 116, pp.S89-S97.

Biomarkers & Social Determinants

1. Metabolic and Immunological Predictors of TB Risk

• TyG index as a risk indicator Elevated TyG index and its derivatives (TyG-WC, TyG-BMI, TyG-WHtR) are linked to increased risk of latent TB infection in adults with normal or impaired glucose tolerance. The association is especially notable in metabolically healthy individuals and is not significant in those with diabetes, indicating TyG is more predictive in earlier stages of metabolic dysfunction.
• Immune response differences after TB exposure Among individuals exposed to TB, those who remain uninfected show distinct immune gene expression profiles compared to those who develop latent infection. Key differences include heightened CD8+ T-cell activity in uninfected individuals and increased IL-17, TNF, and mast cell signaling in infected individuals.
• Potential biomarkers for early TB risk detection Specific genes such as ATG-7, CXCL-3, and TNFRSF1B may serve as early warning markers for TB susceptibility after exposure, offering opportunities for early diagnosis or risk stratification.

See also: Lin TB Lab

---

2. Environmental and Behavioral Risk Factors for TB Spread and Management

• Exposure time strongly influences TB transmission Individuals exposed to active TB cases for more than 6 hours per day are nearly seven times more likely to contract the infection than those exposed for under 6 hours per week. Children under 5 and immigrants are particularly high-risk groups for TB transmission, suggesting the need for prioritized interventions in these populations.
• Health beliefs and treatment adherence TB patients with higher perceived risk (susceptibility), perceived treatment benefits, and support from others are more likely to follow their treatment regimen. Perceived barriers and low self-efficacy negatively affect adherence, highlighting the role of psychological and social factors in treatment outcomes.
• Behavior change can improve outcomes Tailoring interventions to improve risk perception, reduce perceived barriers, and build patient confidence may significantly boost adherence and overall TB control efforts.

See also: YL Samodra

---

3. Long-Term Health Consequences of TB

• Pulmonary TB increases long-term risk of COPD Individuals with a history of TB are two to three times more likely to develop chronic obstructive pulmonary disease (COPD), even after accounting for smoking and other lifestyle factors. This association is strongest among older adults and people with lower education, indicating a compounded effect of biological vulnerability and social disadvantage.
• Implication for post-TB care TB history should be routinely considered in COPD risk assessment and follow-up care, even years after TB recovery. Preventing TB can have added benefits in reducing the future burden of chronic lung disease.

References:

1. Qi, M., Qiao, R. and He, J.Q., 2025. The association between triglyceride-glucose index and related parameters and risk of tuberculosis infection in American adults under different glucose metabolic states: a cross-sectional study. BMC Public Health, 25(1), pp.1-11.
2. Qi, X., Yang, Q., Cai, J., Wu, J., Gao, Y., Ruan, Q., Shao, L., Liu, J., Zhou, X., Zhang, W. and Jiang, N., 2024. Transcriptional profiling of human peripheral blood mononuclear cells in household contacts of pulmonary tuberculosis patients provides insights into mechanisms of Mycobacterium tuberculosis control and elimination. Emerging Microbes & Infections, 13(1), p.2295387.
3. Godoy, S., Parrón, I., Millet, J.P., Caylà, J.A., Follia, N., Carol, M., Orcau, A., Alsedà, M., Toledo, D., Plans, P. and Ferrús, G., 2024. Risk of tuberculosis among pulmonary tuberculosis contacts: the importance of time of exposure to index cases. Annals of Epidemiology, 91, pp.12-17.
4. Wang, J., Yu, L., Yang, Z., Shen, P., Sun, Y., Shui, L., Tang, M., Jin, M., Chen, B., Ge, Y. and Lin, H., 2025. Development of chronic obstructive pulmonary disease after a tuberculosis episode in a large, population-based cohort from Eastern China. International journal of epidemiology, 54(2), p.dyae174.
5. Suprijandani, S., Setiawan, S., Pathurrahman, P., Wardoyo, S. and Rahayyu, A.M., 2025. The behaviour of TB patients in East Lombok through a health belief model approach. Journal of Health, Population and Nutrition, 44(1), p.23.

Yoseph L. Samodra

TBC 067